These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 32439399)

  • 1. Decoding Parkinson's disease - iPSC-derived models in the OMICs era.
    Krach F; Bogiongko ME; Winner B
    Mol Cell Neurosci; 2020 Jul; 106():103501. PubMed ID: 32439399
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mitochondrial Phenotypes in Parkinson's Diseases-A Focus on Human iPSC-Derived Dopaminergic Neurons.
    Heger LM; Wise RM; Hees JT; Harbauer AB; Burbulla LF
    Cells; 2021 Dec; 10(12):. PubMed ID: 34943944
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modeling Parkinson's Disease Using Patient-specific Induced Pluripotent Stem Cells.
    Li H; Jiang H; Zhang B; Feng J
    J Parkinsons Dis; 2018; 8(4):479-493. PubMed ID: 30149462
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induced pluripotent stem cell (iPSC)-derived dopaminergic models of Parkinson's disease.
    Beevers JE; Caffrey TM; Wade-Martins R
    Biochem Soc Trans; 2013 Dec; 41(6):1503-8. PubMed ID: 24256244
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Successful function of autologous iPSC-derived dopamine neurons following transplantation in a non-human primate model of Parkinson's disease.
    Hallett PJ; Deleidi M; Astradsson A; Smith GA; Cooper O; Osborn TM; Sundberg M; Moore MA; Perez-Torres E; Brownell AL; Schumacher JM; Spealman RD; Isacson O
    Cell Stem Cell; 2015 Mar; 16(3):269-74. PubMed ID: 25732245
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Single-Cell Sequencing of iPSC-Dopamine Neurons Reconstructs Disease Progression and Identifies HDAC4 as a Regulator of Parkinson Cell Phenotypes.
    Lang C; Campbell KR; Ryan BJ; Carling P; Attar M; Vowles J; Perestenko OV; Bowden R; Baig F; Kasten M; Hu MT; Cowley SA; Webber C; Wade-Martins R
    Cell Stem Cell; 2019 Jan; 24(1):93-106.e6. PubMed ID: 30503143
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dissecting the non-neuronal cell contribution to Parkinson's disease pathogenesis using induced pluripotent stem cells.
    Pons-Espinal M; Blasco-Agell L; Consiglio A
    Cell Mol Life Sci; 2021 Mar; 78(5):2081-2094. PubMed ID: 33210214
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transcriptomics analysis of human iPSC-derived dopaminergic neurons reveals a novel model for sporadic Parkinson's disease.
    Krauskopf J; Eggermont K; Madeiro Da Costa RF; Bohler S; Hauser D; Caiment F; de Kok TM; Verfaillie C; Kleinjans JC
    Mol Psychiatry; 2022 Oct; 27(10):4355-4367. PubMed ID: 35725899
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Single-Cell Transcriptomics of Parkinson's Disease Human In Vitro Models Reveals Dopamine Neuron-Specific Stress Responses.
    Fernandes HJR; Patikas N; Foskolou S; Field SF; Park JE; Byrne ML; Bassett AR; Metzakopian E
    Cell Rep; 2020 Oct; 33(2):108263. PubMed ID: 33053338
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SNCA triplication Parkinson's patient's iPSC-derived DA neurons accumulate α-synuclein and are susceptible to oxidative stress.
    Byers B; Cord B; Nguyen HN; Schüle B; Fenno L; Lee PC; Deisseroth K; Langston JW; Pera RR; Palmer TD
    PLoS One; 2011; 6(11):e26159. PubMed ID: 22110584
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induced dopaminergic neurons: A new promise for Parkinson's disease.
    Xu Z; Chu X; Jiang H; Schilling H; Chen S; Feng J
    Redox Biol; 2017 Apr; 11():606-612. PubMed ID: 28110217
    [TBL] [Abstract][Full Text] [Related]  

  • 12. What we can learn from iPSC-derived cellular models of Parkinson's disease.
    Caiazza MC; Lang C; Wade-Martins R
    Prog Brain Res; 2020; 252():3-25. PubMed ID: 32247368
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Precision Medicine in Parkinson's Disease Using Induced Pluripotent Stem Cells.
    Kim MS; Kim H; Lee G
    Adv Healthc Mater; 2024 Aug; 13(21):e2303041. PubMed ID: 38269602
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Organoid and pluripotent stem cells in Parkinson's disease modeling: an expert view on their value to drug discovery.
    Marotta N; Kim S; Krainc D
    Expert Opin Drug Discov; 2020 Apr; 15(4):427-441. PubMed ID: 31899983
    [No Abstract]   [Full Text] [Related]  

  • 15. The NAD+ Precursor Nicotinamide Riboside Rescues Mitochondrial Defects and Neuronal Loss in iPSC and Fly Models of Parkinson's Disease.
    Schöndorf DC; Ivanyuk D; Baden P; Sanchez-Martinez A; De Cicco S; Yu C; Giunta I; Schwarz LK; Di Napoli G; Panagiotakopoulou V; Nestel S; Keatinge M; Pruszak J; Bandmann O; Heimrich B; Gasser T; Whitworth AJ; Deleidi M
    Cell Rep; 2018 Jun; 23(10):2976-2988. PubMed ID: 29874584
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Implications of Parkinson's disease pathophysiology for the development of cell replacement strategies and drug discovery in neurodegenerative diseases.
    Pan-Montojo F; Funk RH
    CNS Neurol Disord Drug Targets; 2012 Nov; 11(7):907-20. PubMed ID: 23131153
    [TBL] [Abstract][Full Text] [Related]  

  • 17. iPSC-derived dopamine neurons reveal differences between monozygotic twins discordant for Parkinson's disease.
    Woodard CM; Campos BA; Kuo SH; Nirenberg MJ; Nestor MW; Zimmer M; Mosharov EV; Sulzer D; Zhou H; Paull D; Clark L; Schadt EE; Sardi SP; Rubin L; Eggan K; Brock M; Lipnick S; Rao M; Chang S; Li A; Noggle SA
    Cell Rep; 2014 Nov; 9(4):1173-82. PubMed ID: 25456120
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of Parkinson's Disease through Personalized Medicine and Induced Pluripotent Stem Cells.
    Stoddard-Bennett T; Reijo Pera R
    Cells; 2019 Jan; 8(1):. PubMed ID: 30621042
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Parkinson's Disease-Associated Changes in the Expression of Neurotrophic Factors and their Receptors upon Neuronal Differentiation of Human Induced Pluripotent Stem Cells.
    Novosadova EV; Nenasheva VV; Makarova IV; Dolotov OV; Inozemtseva LS; Arsenyeva EL; Chernyshenko SV; Sultanov RI; Illarioshkin SN; Grivennikov IA; Tarantul VZ
    J Mol Neurosci; 2020 Apr; 70(4):514-521. PubMed ID: 31820346
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Modeling Familial Parkinson's Disease Using Patient-specific Induced Pluripotent Stem Cells].
    Tabata Y; Okano H
    Brain Nerve; 2019 Aug; 71(8):875-883. PubMed ID: 31346144
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.